News

Research is underway into creating a microparticle drug delivery system that mimics the properties of a red blood cell.

A ubiquitous protein called sigma 1 receptor, which is known to protect cells from stress, appears key to the function and survival of the neurons most impacted by glaucoma, scientists report.

Researchers from two independent research teams have discovered how the mislocalization of a protein "TDP-43" changes the genetic instructions for UNC13A, providing a possible therapeutic target for specific neurodegenerative disorders.

According to research, statins, which are prescribed as cholesterol-lowering drugs, inhibit the expression of a metastasis-associated gene in tumor cells.

Researchers have developed a new precision medicine technology that can carry out comprehensive mapping of the whole cell surface tumor antigen landscape in patients. The technology could help to create new successful immunotherapies to treat cancer.

A clinical trial that added an immunotherapy drug to standard of care treatment regimens has shown increased survival rates for head and neck cancer patients with intermediate risk features.

Extract from the bark of the Neem tree may help treat and reduce the spread of coronavirus, according to a new study led by scientists at the University of Colorado Anschutz Medical Campus and the Indian Institute of Science Education and Research Kolkata.

The molecular structure of the multiple sclerosis drug interacting with its target has been detailed, revealing how the drug could be modified to prevent side effects from off-target binding.

UC Riverside-led study shows how an effective therapy against SARS-CoV-2 could be developed.

The grand prize winner of the inaugural Michelson Philanthropies & Science Prize for Immunology has illuminated factors that underlie varied susceptibilities to COVID-19.